ArticleEndocrinology2026
A protocol for physiologic LH surge induction in gonad intact female mice.
Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The preovulatory luteinizing hormone (LH) surge is a defining neuroendocrine event that triggers ovulation through estradiol (E2)-dependent positive feedback on gonadotropin-releasing hormone (GnRH) secretion. Mechanistic studies of this process have relied predominantly on ovariectomized rodents supplemented with exogenous hormones, a paradigm that disrupts ovarian function and limits physiological and translational relevance. Here, we establish a robust and reproducible model of LH surge induction in intact female mice that preserves the hypothalamic-pituitary-gonadal axis. We show that a single low-dose injection of estradiol benzoate (EB; 0.5 µg) administered during diestrus reliably induces a temporally synchronized LH surge in most intact females, whereas EB treatment during proestrus or estrus is ineffective. EB-induced LH surges were accompanied by a significant increase in circulating progesterone, confirming the engagement of ovarian luteinizing pathways. The LH surge occurrence was independent of proestrus detection by vaginal cytology, accentuating the limited predictive value of cytology in mice. At the neuroendocrine level, EB treatment markedly increased cFOS expression in GnRH neurons across key preoptic regions and modestly activated kisspeptin neurons in the rostral periventricular area of the third ventricle, consistent with activation of E2-positive feedback circuitry. In contrast, arcuate kisspeptin neurons remained inactive, supporting their role in negative feedback. Together, these findings define a physiologically relevant, intact mouse model for studying E2-induced LH surges that maintains endogenous ovarian signaling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.